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Analysis of data collected during the Canada Health Survey of 1978-1979 indicated a positive
relationship between blood lead and blood pressure, but so weak that the range of lead-related
variation among members of the general public was estimated to be at most 3.0 mm Hg of diastolic
pressure. Even so, a blood lead level in excess of the median value of 10 Pg/dL entailed a 37% higher
risk ofhaving diastolic pressure above 90 mm Hg.
In a longitudinal study of lead foundry workers, an association was found between short-term
changes in an individual's blood lead level and contemporary changes in diastolic pressure; this
remained significant after allowance for age (or time) trends and for effects attributable to changes in
body weight. Short-term changes in urinary cadmium levels were similarly predictive of diastolic
pressure.
In the controversy that followed the publication of
the results of Harlan et al. analysis ofthe NHANES data
(1), indicating the possibility of a causal relationship
between blood lead levels and blood pressure, there were
those who argued that the relationship found merely
reflected the concurrent time trends of these two
causally unrelated variables. It seemed to us that the
most nearly appropriate source of independently
acquired data from which to confirm the type of rela-
tionship described by Harlan et al. should this be a
feature of the North American population as a whole,
was the Canada Health Survey (CHS) (2).
Cross-Sectional Study of
General Population Sample
A particular merit of the Canadian population data
is that the data were collected during the period of only
10 months, during 1978-1979, compared with 49
months which elapsed during NHANES II. This
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greatly reduces the risk of confounding between blood
lead and any unidentified variable that happened to
have a similar time trend. Details of design, as well as
descriptive statistics derived from the CHS, have been
published by the responsible government agencies.
Analysis has been focused on persons aged 25 and over,
and we have generally excluded that part of the popu-
lation over the age of 65 which has already been
substantially depleted by cardiovascular deaths so that
hypertensive status among the survivors is harder to
interpret. Subjects under treatment for hypertension
were excluded from our analyses, except in those cases
where they appear as a separate class. As separate regres-
sions for males and females gave substantially similar
results, itwas decided to use both sexes together.
For 2193 CHS subjects aged 25 to 64, the zero-order
correlation between diastolic blood pressure and blood
lead level was found to be 0.115. Though this associa-
tion is a weak one (as was also the case in the NHANES
II data), its statistical significance is not in doubt
(p < 0.001). It must be noted that the strength of the
association owes something to the circumstance that
males tend to have higher values than females both for
blood pressure and for blood lead. Because of the well-
known tendency of blood pressure to increase with age,
it was appropriate to use age as a control variable, even
though there is no strong or regular relationshipNERI, HEWI7T, AND ORSER
between age and blood lead in the CHS. The next most
important control variable was body build [indexed in
the CHS by the ratio weight (kg)/height2 (m)],which
had a fairly strong correlation with blood lead in the
CHS (r= 0.257).
After examining all the intercorrelations among
nine possible confounder variables, two were selected
for inclusion, namely serum zinc and hemoglobin
level, so that the multiple regression equations com-
puted had up to six independent variables. In addition
to the linear model, we also used models in which
blood lead measurements were subjected to logarithmic
transformations. In contrast to the NHANES II data
where the minimum blood lead concentration of 9933
values was 2 ,ug/dL (1), the CHS data included a sub-
stantial number of values below the limit of detection,
making it necessary to add some positive quantity to
the recorded value of zero before taking the logarithm:
We experimented with arbitrary constants set at 0.1,
1.0, 3.0, and 5.0, and also with a function ofthe recorded
value set so as to make cumulative frequency dis-
tribution of the logged values exactly Gaussian.
Table 1 shows results of testing the one-sided alter-
native hypothesis that there is a positive relationship
between blood lead level and blood pressure (excluding
subjects on antihypertensive medication). Table 1
shows p-values that were derived from F-ratios asso-
ciated with the regression coefficient on blood lead in
each model. All but one version of the regression em-
ploying three control variables attained significance at
the conventional 5% level, but none of those employing
control for zinc and hemoglobin attained significance.
From the right-hand column of Table 1, it appears
that the amount of influence ascribed to blood lead by
the logarithmic model may be very sensitive to the
adjustment used. The estimated change in blood pres-
sure per unit change in the transformed lead mea-
surement ranged from as low as 0.10 [with ln(x + 0.1)]
to 0.68 [with In (x + f(x)].
Using the parameter estimate given in Pirkle et al.
(3) with the logarithmic model, the reduction in
mean pressure achieved by successive 5.0 ,ug/dL
reductions, starting from 20.0 ,ug/dL, would be as
Table 1. Significance ofpartial regression coefficients
ofdiastolic blood pressure on blood lead level.a
p-Values
Three control Five control
Model variablesb variablesC
Linear 0.041 0.104
Logarithmic
ln (x + 0.01) 0.113 0.242
ln (x + 1.0) 0.034 0.114
In (x + 3.0) 0.032 0.108
In (x + 5.0) 0.033 0.107
ln (x+f(x))d 0.039 0.114
aSubjects not on antihypertensive medication.
bVariables: age, sex, body build.
CVariables: age, sex, body build, percent hemoglobin, serum zinc.
df(x) chosen to make lead variable exactly log-normal.
Table 2. Predicted difference in mean diastolic blood
pressure between subjects whose blood lead levels are
0.0 pg/dL and 47 pg/dL.a
Difference in mean diastolic blood pressure, mm Hg
Three control Five control
Model variablesb variablesb
linear 3.0 2.1
ln (x + 0.01) 2.1 1.4
aData of Canada Health Survey for subjects not on antihypertensive
medication.
follows: 1.14 mm Hg, 1.60 mm Hg, 2.74 mm Hg, and
something in excess of 6.4 mm Hg. If this model (with
the same parameter estimate) described the Canadian
population, then we should expect to find a more than
15-mm Hg difference in mean diastolic blood pressure
between the extremes of blood lead level seen in CHS
subjects (namely, 47 ,ug/dL and 0, taken here as 1.0
,ug/dL). In fact, as Table 2 shows, the range of lead-
related variation in blood pressure apparent in
Canadian data is estimated to be at most 3.0 mm Hg
(that is 0.064 mm Hg per unit of blood lead) and
possibly not over 1.4 mm Hg.
An attempt has been made to obtain another per-
spective on the possible public health significance of the
lead/blood pressure association by using an analysis
based on categories (such as blood pressure above/
below 90 mm Hg), as distinct from the regression
analysis based on blood pressure as a continuous vari-
able. For this purpose we calculated prevalence rates of
antihypertensive medication use and of elevated blood
pressure, using as numerators and denominators
estimates for the Canadian population furnished by
Health and Welfare Canada. Thus, this analysis
adjusted for the design effects of the CHS, which our
unweighted regression analysis did not. [In the re-
gression analysis of CHS blood pressure data in rela-
tion to alcohol consumption carried out by Coates et al.
(4), it was found that adjustment for design effects
made little difference to the results obtained.] On the
other hand, the prevalence analysis used included
only two control variables: sex and body build (with 25
as the boundary value of the index separating "slim"
from "not-so-slim").
Table 3 shows prevalence rates for the characteristic
"using antihypertensive medication" and (within
the population not using such medication) for the
characteristic "diastolic blood pressure over 90 mm
Hg." Table 4 gives estimates of relative risk (RR)
derived from an (unweighted) log-linear analysis of
the prevalence rates shown inTable 3. Asexpected, males
are substantially more likely than females to have ele-
vated blood pressure (RR = 1.64), but less likely to have
sought (or to have complied with) medical treatment
for it (RR = 0.62). Body builds other than slim entail a
fourfold risk of antihypertensive medication and, in
untreated subjects, a doubling of the prevalence of
elevated blood pressure (over 90 mm Hg). The
influence ofblood lead appears to be much weaker than
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Table 3. Prevalence oftwo mutually exclusive conditions
suggestive ofhypertension.a
Blood lead level, Vig/dL
<10 .10 <10 >10
Condition Males Females
Slimb
Use medication, % 0.91 8.84 3.98 2.74
Diastolic pressure 12.0 18.0 6.4 7.3
> 90mm Hg, %
Not so slimc
Use medication, % 10.95 5.75 17.56 17.45
Diastolic pressure 24.7 25.7 17.9 22.9
>90 mm Hg, %
aCanadians age 25 to 64 years.
bWeight/height2 < 25.
CWeight/height2 > 25.
Table 4. Relative risk oftwo conditions suggestive of
hypertension associated with three independently acting
risk factors.
Diastolic blood pressure
> 90mm Hg and not
On antihypertension on antihypertension
Risk factor medication medication
Sex, male 0.62 (0.23-1.63)a 1.64 (1.09-2.44)
Body build, 3.85 (0.89-16.6) 2.25 (1.50-3.40)
weight/height2
> 25.0
Blood lead, 1.37 (0.06-31.4) 1.23 (1.02-1.48)
> 10pg/dL
aNumbers in parentheses are confidence limits.
that of either of these control variables and, in the case
of drug use, only one of the four widely varying
estimates of relative risk obtained from Table 3 exceeds
unity. In the case of elevated blood pressure, however,
all four of the independent estimates of relative risk
exceed unity and, provided this is agreed to be a one-
tailed test situation, we may conclude that the average
of these values provides conventionally significant
evidence against the null hypothesis (t = 2.61, using
the logarithms of the four estimates).
Our overall conclusion up to this point was that
Canadian data were at least weakly supportive of the
inference drawn from NHANES II, in that elevation of
blood lead did seem to entail some risk ofblood pressure
elevation. It would have been premature, in the absence
of longitudinal data, to infer that this was a cause-and-
effect relationship.
Longitudinal Study of an
Occupationally Exposed Group
A search was therefore made in Canada for any
group of subjects whose blood lead levels and blood
pressure had been measured repeatedly. By studying
the variation within individual subjects over time, it
was hoped to obtain control over most of the potential
confounders that could afflict a cross-sectional study,
while the inclusion of age as an independent variable
would control for time trends. A suitable study popu-
lation was identified at foundry B, where over 500
subjects had been examined annually for periods of up
to 14years.
Though the blood pressure records showed some
evidence ofdigit preference (excessive numbers of even
values and multiples of 5), the overall distribution was
in good agreement with expectation, having an
individual variance (diastolic) of about 100 mm' Hg.
This body of data was therefore judged suitable for
testing the hypothesis that, within individuals, blood
pressure and blood lead level tend to rise and fall
together. Statistically significant support for the latter
hypothesis would enhance the credibility of a cause-
and-effect relationship between the two variables.
Preliminary analysis was carried out by multiple
linear regression using the individual employee as
the unit of study, with blood pressure (either diastolic
or systolic) as the dependent variable. Although for the
majority of subjects data are available for 14 years, the
present report shows results based exclusively on the
period 1979-1985.
From a total of 288 regression estimates of the de-
pendence of diastolic pressure on age, we see in Table 5
that the average rate of increase was 1.161 mm Hg per
year. Likewise, each additional kilogram of body
weight added an average of 0.312 mm Hg to the dias-
tolic pressure. (Because the height of each adult subject
could be assumed constant, weight, rather than its
ratio to height, was used in the longitudinal analysis.)
From these same equations the average change in
diastolic pressure per microgram per deciliter of lead
was estimated to be 0.298 mm Hg, a quantity that
exceeds 2.5 times its standard error. The corresponding
value for systolic blood pressure was only 0.210 mm
Hg, which falls just short of conventional significance
(one-tailedp = 0.064).
Interpretation of these results should take into ac-
count the concurrent exposure of lead workers to cad-
mium in the smelter environment, since cadmium
has been implicated both in experimental and clinical
studies of hypertension. Fortunately, determinations
of urinary cadmium were begun on a routine basis in
1979 and were available for all subjects included in the
analysis described previously. As more data accumu-
Table 5. Estimates of mean change in blood pressure per
unit change in certain other variables.
Mean change, mm Hg
Variable Diastolic Systolic
Age, per year 1.161 ± 0.293 0.502 + 0.355
t=3.96 t= 1.41
Weight, per kg 0.312 ± 0.172 0.356 + 0.185
t=1.81 t=1.93
Blood lead, 0.298 + 0.111 0.210 + 0.139
perVg/dL t=2.67 t= 1.52
Critical values oft285 2-tailed 1-tailed
5% level 1.97 1.65
1% level 2.59 2.34
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late, the possibility of distinguishing between the
effects of these two metals will improve. Table 6 shows
results of a regression analysis in which cadmium, as
well as lead, has been used as an independent variable.
However, because of the limited number of data points
per subject, it was necessary at this stage to exclude the
weight variable, so the results are not directly com-
parable with those in Table 5. The mean values of the
coefficients for lead and cadmium are both positive, but
neither can be considered independently significant.
Of the two coefficients, that related to cadmium is likely
to be the more attenuated by instability of urinary
cadmium levels. We also calculated 281 within-subject
regression equations for diastolic pressure using cad-
mium instead of blood lead, while retaining age and
body weight as control variables. In 214 of these equa-
tions (a proportion of 0.562), the coefficient for cadmi-
um was positive, a clearly significant result (p = 0.008).
In the corresponding analysis for systolic pressure, the
proportion of positive coefficients was only 0.441, again
failing to match the effect seen for diastolic pressure.
Within this occupationally exposed group, there is
known to be a positive correlation between the levels of
these two metals: This may well be the case also in the
population at large. The problem of distinguishing a
lead effect from a cadmium effect must therefore be of
concern for all investigators in this field.
Two other points also have to be considered: a) the
form of the dose-response relationship (bearing both
on the reconciliation of results from occupationally
exposed groups with those from general population
samples, and on the public health use one can make of
the estimates), and b) the question of time lag or cum-
Table 6. Estimates of mean change in blood pressure per unit
change in certain other variables.
Mean change in diastolic
Variable pressure, mm Hg
Age, peryear 1.483 + 0.185
t=8.03
Blood lead, 0.079 + 0.096
perpg/dL t=0.82
Urinary cadmium, 0.262 + 0.518
per pg/dL t=0.51
Criticalvalues oft282 2-tailed 1-tailed
5% level 1.97 1.65
1% level 2.59 2.34
ulative effects. These points are discussed in the
following section.
Discussion
An assumption of the present analysis was that any
dependence of blood pressure on lead level would be
simply linear. In the analysis of Pirkle et al. (3), a log-
arithmic model was postulated, under which a given
absolute increment in blood lead level would have a
much greater effect on a subject in the lower (general
population) range than on one in the upper (occupa-
tionally exposed) range. Examination of a subset of
foundry B employees whose lead levels showed espe-
cially large fluctuations on a ratio scale (at least dou-
bling or halving within the period of observation)
produced no support for the idea of a dependence of
blood pressure on logarithm oflead level.
A second, and less comfortable assumption was that
the effects on blood pressure of variation in blood lead
level (and also of variation in body weight) would be
expressed immediately, or after an interval that was
short in relation to the interval between examinations
(usually about 12 months). If this assumption is in-
correct, then the association between blood pressure and
blood lead (as well as body weight) could be more reg-
ular and more important than present results suggest.
Analysis ofthe Canada Health Survey Data was carried out on behalf
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